Study of clinical pharmacokinetics of Micafungin in patients with extensive burn

Study of clinical pharmacokinetics of Micafungin in patients with extensive burn - Study of clinical pharmacokinetics of Micafungin in patients with extensive burn

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004815

Enrollment

Registered

2011-01-05

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

extensive burn

Interventions

Micafungin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with extensive burn of TBSA 30% or more 2) Adults of 20 years old or older 3) Patients who consents by himself, his legal representative or guardian

Exclusion criteria

Exclusion criteria: 1) Patients with a history of hypersensitivity to MIcafungin

Design outcomes

Primary

Measure	Time frame
To investigate the appropriate therapeutic regimen of Micafungine in extensive burn patients based on the pharmacokinetics and the drug concentrations in burned tissue	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026